Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT00198094
Eligibility Criteria:
Inclusion Criteria:
* Subjects will include men and women over the age of eighteen;
* the ability to give written informed consent;
* current principal or co-principal psychiatric diagnosis of panic disorder with or without agoraphobia based on DSM-IV criteria (American Psychiatric Association, 1994);
* willing to use an effective means of contraception;
* free of psychoactive medications for at least 2 weeks prior to study enrollment;
* not actively be suicidal.
Exclusion Criteria:
* actively suicidal;
* medical conditions for which either sertraline or alprazolam XR would be contraindicated;
* recent six month history of substance or alcohol abuse;
* history or presence of psychotic or bipolar disorder;
* women who are pregnant or breastfeeding;
* history or presence of a seizure disorder or a known history of more than one childhood febrile seizure;
* presence of a personality disorder severe enough to compromise the investigator's ability to evaluate the efficacy and safety of the study medication;
* concomitant therapy with other psychotropic medication(s);
* clinically significant abnormality during physical examination, vital signs, EKG, urine drug screen, or laboratory tests at the screen visit.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00198094
Study Brief:
Protocol Section:
NCT00198094